Verona Pharma (VRP)

 

Latest News

Verona Pharma plc : Total voting rights

Verona Pharma plc: Total voting rights October 2, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), in conformity with DTR 5.6 of the FCA's Disclosure and Transparency Rules, notifies the market that as at 30 September 2017, the issued ordinary share capital of the Company consisted of 105,017,401 ordinary shares with votin...

Best AIM companies of 2017

The annual AIM Awards are almost upon us, so former AIM writer of the year Andrew Hore names the small-cap compa...

Verona Pharma Reports Positive Top-Line Data from U.S. Pharmacokinetic Trial Demonstrating Nebulized RPL554 Delivers Optimal Clinical Dose to Patients

Verona Pharma Reports Positive Top-Line Data from U.S. Pharmacokinetic Trial Demonstrating Nebulized RPL554 Delivers Optimal Clinical Dose to Patients Earlier than expected results demonstrate absorption occurs primarily in the lungs following inhaled administration LONDON, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDA...

Verona to issue shares

Verona Pharma has announced that it will issue 133,333 new ordinary shares following an exercise of share options by N+1...

All News

DateHeadlineSource
02-10-17Verona Pharma plc : Total voting rightsRNS
29-09-17Best AIM companies of 2017 Interactive Investor
27-09-17Verona Pharma Reports Positive Top-Line Data from U.S. Pharmacokinetic Trial Demonstrating Nebulized RPL554 Delivers Optimal Clinical Dose to PatientsRNS
19-09-17Verona to issue sharesStockMarketWire
19-09-17Verona Pharma plc : MiscellaneousRNS
07-09-17Verona Pharma Announces Positive Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)RNS
01-09-17Verona Pharma Appoints Stifel as Nominated AdviserRNS
21-08-17Director Deals - Verona Pharma PLC (VRP)StockMarketWire
21-08-17PDMR DealingRNS
08-08-17Verona Pharma losses widen as it starts clinical trialsStockMarketWire
08-08-17Verona Pharma plc Interim Results for the Six Months Ended June 30, 2017 and Clinical Development UpdateRNS
02-08-17Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2017 and Provide Clinical Development UpdateRNS
01-08-17Verona to present at healthcare conferenceStockMarketWire
01-08-17Verona Pharma to Present at 2017 Wedbush PacGrow Healthcare ConferenceRNS
26-07-17Verona Pharma Doses First Patients in Phase 2b Clinical Trial of RPL554 for COPD Maintenance TreatmentRNS
27-06-17Verona nears Phase 2b clinical trial for RPL554StockMarketWire
27-06-17Verona Pharma Receives Regulatory Approval to Commence Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment in Five Countries across EuropeRNS
22-06-17Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory AffairsRNS
06-06-17Verona Pharma plc : Holding(s) in CompanyRNS
06-06-17Verona Pharma plc : Holding(s) in CompanyRNS
05-06-17Verona initiates US clinical pharmacokinetic study for RPL554StockMarketWire
05-06-17Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDARNS
30-05-17Holding(s) in CompanyRNS
30-05-17Holding(s) in CompanyRNS
25-05-17Holding(s) in CompanyRNS
25-05-17Verona Pharma Announces Further Exercise of Over-Allotment Option and Resulting Total Voting RightsRNS
23-05-17Verona CEO to present at Jefferies Healthcare ConferenceStockMarketWire
23-05-17Verona Pharma to Present at Jefferies 2017 Global Healthcare ConferenceRNS
23-05-17Holding(s) in CompanyRNS
22-05-17Broker Forecast - Jefferies International issues a broker note on Verona Pharma PLCStockMarketWire
16-05-17Partial Exercise of Over-Allotment OptionRNS
08-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
03-05-17Holding(s) in CompanyRNS
03-05-17Block Listing Application and ReviewRNS
03-05-17Grant of Options and RSUs and PDMR DealingsRNS
02-05-17Closing of Global Offering and Total Voting RightsRNS
02-05-17Director/PDMR ShareholdingRNS

RSS feeds

  • Editorial news feed for LSE:VRP Editorial
  • Regulatory news feed for LSE:VRP Regulatory